427 related articles for article (PubMed ID: 14705239)
1. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.
Alsufyani K; Ortiz-Alvarez O; Cabral DA; Tucker LB; Petty RE; Malleson PN
J Rheumatol; 2004 Jan; 31(1):179-82. PubMed ID: 14705239
[TBL] [Abstract][Full Text] [Related]
2. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis.
Woo P; Southwood TR; Prieur AM; Doré CJ; Grainger J; David J; Ryder C; Hasson N; Hall A; Lemelle I
Arthritis Rheum; 2000 Aug; 43(8):1849-57. PubMed ID: 10943876
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.
Gerloni V; Pontikaki I; Gattinara M; Desiati F; Lupi E; Lurati A; Salmaso A; Fantini F
Arthritis Rheum; 2005 Feb; 52(2):548-53. PubMed ID: 15693004
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A;
Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
[TBL] [Abstract][Full Text] [Related]
5. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ
Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975
[TBL] [Abstract][Full Text] [Related]
6. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
[TBL] [Abstract][Full Text] [Related]
7. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
Schmeling H; Biber D; Heins S; Horneff G
J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
[TBL] [Abstract][Full Text] [Related]
8. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM
Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
Horneff G; De Bock F; Foeldvari I; Girschick HJ; Michels H; Moebius D; Schmeling H;
Ann Rheum Dis; 2009 Apr; 68(4):519-25. PubMed ID: 18413440
[TBL] [Abstract][Full Text] [Related]
12. Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis.
Masi L; Ricci L; Zulian F; Del Monte F; Simonini G; Capannini S; De Martino M; Brandi ML; Falcini F
J Rheumatol; 2009 Oct; 36(10):2308-13. PubMed ID: 19684155
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis: an observational study with patients from the German Methotrexate Registry.
Klein A; Kaul I; Foeldvari I; Ganser G; Urban A; Horneff G
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1349-56. PubMed ID: 22649024
[TBL] [Abstract][Full Text] [Related]
14. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis.
Ravelli A; Di Fuccia G; Molinaro M; Ramenghi B; Zonta L; Regazzi MB; Martini A
J Rheumatol; 1993 Sep; 20(9):1573-7. PubMed ID: 8164218
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis.
Foeldvari I; Wierk A
J Rheumatol; 2005 Feb; 32(2):362-5. PubMed ID: 15693100
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis.
Ortiz-Alvarez O; Morishita K; Avery G; Green J; Petty RE; Tucker LB; Malleson PN; Cabral DA
J Rheumatol; 2004 Dec; 31(12):2501-6. PubMed ID: 15570658
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate in the treatment of children with chronic arthritis--long-term observations of efficacy and safety.
Huang JL
Br J Clin Pract; 1996 Sep; 50(6):311-4. PubMed ID: 8983319
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML
Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the pharmacokinetics of MTX in juvenile idiopathic arthritis patients receiving long-term MTX monotherapy or MTX plus chloroquine.
Kimura E; Oga S; Pereira RM
J Clin Pharm Ther; 2007 Dec; 32(6):579-84. PubMed ID: 18021335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
